144 related articles for article (PubMed ID: 37319003)
21. [Myositis as a 'radiation-recall phenomenon' following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma].
Pinson PJ; Griep C; Sanders WH; Lelie B
Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1891-4. PubMed ID: 16970014
[TBL] [Abstract][Full Text] [Related]
22. A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report.
Verschoor AJ; Warmerdam FARM; Bosse T; Bovée JVMG; Gelderblom H
BMC Cancer; 2018 Jan; 18(1):92. PubMed ID: 29357824
[TBL] [Abstract][Full Text] [Related]
23. Pazopanib-induced fatal heart failure in a patient with unresectable soft tissue sarcoma and review of literature.
Karaağaç M; Eryılmaz MK
J Oncol Pharm Pract; 2020 Apr; 26(3):768-774. PubMed ID: 31547750
[TBL] [Abstract][Full Text] [Related]
24. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
25. Vastus lateralis myocutaneous flap for ischial skin wound following the treatment of epithelioid sarcoma using pazopanib.
Tsujii M; Matsumine A; Nakamura T; Satonaka H; Sudo A
J Wound Care; 2020 Jun; 29(6):335-339. PubMed ID: 32530777
[TBL] [Abstract][Full Text] [Related]
26. Thermal Monitoring of Tumor and Tissue State during Radiation Therapy - A Complex Case of Radiation Recall.
Ben-David MA; Hoffer O; Kirshenabum D; Katz E; Alezra D; Symon Z; Rabin T; Zimmer Y; Kelson I; Gannot I
Crit Rev Biomed Eng; 2020; 48(2):125-131. PubMed ID: 33389900
[TBL] [Abstract][Full Text] [Related]
27. Characterizing the phenomenon of radiation recall dermatitis.
Camidge R; Price A
Radiother Oncol; 2001 Jun; 59(3):237-45. PubMed ID: 11369064
[TBL] [Abstract][Full Text] [Related]
28. Radiation recall dermatitis induced by sorafenib : A case study and review of the literature.
Stieb S; Riesterer O; Brüssow C; Pestalozzi B; Guckenberger M; Weiler S
Strahlenther Onkol; 2016 May; 192(5):342-8. PubMed ID: 26907093
[TBL] [Abstract][Full Text] [Related]
29. [Two Case Reports of Chemotherapy-Induced Radiation Myositis].
Nishibuchi I; Wadasaki K
Gan To Kagaku Ryoho; 2018 Jun; 45(6):1005-1007. PubMed ID: 30026433
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced bullous pemphigoid after surgery for soft tissue sarcoma: About a rare case.
Gandolfi S; Berthier C; Marcaillou M; Lafaye G; Meresse T
Ann Chir Plast Esthet; 2021 Oct; 66(5):410-412. PubMed ID: 34020818
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond).
Carroll C; Patel N; Gunsoy NB; Stirnadel-Farrant HA; Pokras S
Future Oncol; 2022 Oct; 18(32):3651-3665. PubMed ID: 36399116
[TBL] [Abstract][Full Text] [Related]
32. Focal myositis and its differential diagnosis. A case report and review of the literature.
Vercelli-Retta J; Ardao G; De Cabrera M
Ann Pathol; 1988; 8(1):54-6. PubMed ID: 3293581
[TBL] [Abstract][Full Text] [Related]
33. Radiation recall with anticancer agents.
Burris HA; Hurtig J
Oncologist; 2010; 15(11):1227-37. PubMed ID: 21045191
[TBL] [Abstract][Full Text] [Related]
34. The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Nakamura T; Matsumine A; Kawai A; Araki N; Goto T; Yonemoto T; Sugiura H; Nishida Y; Hiraga H; Honoki K; Yasuda T; Boku S; Sudo A; Ueda T
Cancer; 2016 May; 122(9):1408-16. PubMed ID: 26970174
[TBL] [Abstract][Full Text] [Related]
35. Recurrent radiation recall dermatitis triggered by radiological procedures in a patient with breast cancer.
Emre S; Demirseren DD; Unal E; Sungu N
Australas J Dermatol; 2019 Nov; 60(4):308-310. PubMed ID: 31012084
[TBL] [Abstract][Full Text] [Related]
36. Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Weiss AR; Chen YL; Scharschmidt TJ; Chi YY; Tian J; Black JO; Davis JL; Fanburg-Smith JC; Zambrano E; Anderson J; Arens R; Binitie O; Choy E; Davis JW; Hayes-Jordan A; Kao SC; Kayton ML; Kessel S; Lim R; Meyer WH; Million L; Okuno SH; Ostrenga A; Parisi MT; Pryma DA; Randall RL; Rosen MA; Schlapkohl M; Shulkin BL; Smith EA; Sorger JI; Terezakis S; Hawkins DS; Spunt SL; Wang D
Lancet Oncol; 2020 Aug; 21(8):1110-1122. PubMed ID: 32702309
[TBL] [Abstract][Full Text] [Related]
37. Myositis ossificans mimicking sarcoma: a not so rare bioptic diagnostic pitfall.
Cortellazzo Wiel L; Trevisan M; Murru FM; Rabusin M; Barbi E
Ital J Pediatr; 2020 Jul; 46(1):110. PubMed ID: 32736643
[TBL] [Abstract][Full Text] [Related]
38. Frequency of radiation recall dermatitis in adult cancer patients.
Kodym E; Kalinska R; Ehringfeld C; Sterbik-Lamina A; Kodym R; Hohenberg G
Onkologie; 2005 Jan; 28(1):18-21. PubMed ID: 15591727
[TBL] [Abstract][Full Text] [Related]
39. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series.
Verschoor AJ; Gelderblom H
Clin Sarcoma Res; 2014; 4():14. PubMed ID: 25302110
[TBL] [Abstract][Full Text] [Related]
40. Radiation recall reaction: two case studies illustrating an uncommon phenomenon secondary to anti-cancer agents.
Zhu SY; Yuan Y; Xi Z
Cancer Biol Med; 2012 Sep; 9(3):202-4. PubMed ID: 23691480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
